VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Physostigmine
Preclinical
Small molecule
AstraZeneca
2
Indications
9
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Tobacco Smoking
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Tobacco Smoking
Preclinical
Completed
Clinical
Trials by Indication
[1]
Sedation
2 trials
Phamacological Reversal of Airway Instability During Sedation
Completed
·
U
University of Rochester
·
N/A
·
NCT01171118
·
10 enrolled
The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for Colonoscopy
Unknown status
·
R
Rabin Medical Center
·
N/A
·
NCT01121497
·
160 enrolled
General Anesthesia
1 trial
Physostigmine After General Anesthesia
Unknown status
·
—
·
N/A
·
NCT00850850
·
50 enrolled
Insulin resistance
1 trial
Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
Completed
·
AstraZeneca
·
Phase 1
·
NCT00689208
·
12 enrolled
Opioid Analgesia
1 trial
Pilot Study of Physostigmine-Enhanced Opioid Analgesia
Completed
·
M
Medical University of Graz
·
Phase 3
·
NCT01394445
·
20 enrolled
Tobacco Smoking
1 trial
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
Completed
·
Y
Yale University
·
N/A
·
NCT02008292
·
80 enrolled
3 more indications
Adolescent
1 trial
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
Completed
·
U
University of Colorado, Denver
·
Phase 4
·
NCT03090620
·
19 enrolled
Delirium
1 trial
Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery
Unknown status
·
P
PD Dr. Bertram Scheller
·
Phase 3
·
NCT02216266
·
120 enrolled
Unspecified
1 trial
Anticholium® Per Se
Completed
·
U
University Hospital Heidelberg
·
N/A
·
NCT03013322
·
20 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
9 trial records for Physostigmine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Physostigmine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Physostigmine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
AstraZeneca company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
AstraZeneca
Related News